Hesham A. Shamsel-Din, Hany Aglan, Aya Barseem, Doaa A Elsayed, Mohamed A. Gizawy. Design and 99mTc-radiolabeling of an imidazopyridine-hydrazone hybrid: A promising tumor-targeted radiopharmaceutical. // Journal of Pharmaceutical Sciences. – 2027. – DOI: 10.1016/j.xphs.2026.104589. – URL: https://doi.org/10.1016/j.xphs.2026.104589
Hesham A. Shamsel-Din, Hany Aglan, Aya Barseem, Doaa A Elsayed, & Mohamed A. Gizawy (2027). Design and 99mTc-radiolabeling of an imidazopyridine-hydrazone hybrid: A promising tumor-targeted radiopharmaceutical. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2026.104589
Hesham A. Shamsel-Din, et al. “Design and 99mTc-radiolabeling of an imidazopyridine-hydrazone hybrid: A promising tumor-targeted radiopharmaceutical.” Journal of Pharmaceutical Sciences, 2027. doi:10.1016/j.xphs.2026.104589.
@article{ShamselDin2027,
title = {Design and 99mTc-radiolabeling of an imidazopyridine-hydrazone hybrid: A promising tumor-targeted radiopharmaceutical},
author = {Shamsel-Din, Hesham A. and Aglan, Hany and Barseem, Aya and Elsayed, Doaa A and Gizawy, Mohamed A.},
journal = {Journal of Pharmaceutical Sciences},
year = {2027},
doi = {10.1016/j.xphs.2026.104589},
url = {https://doi.org/10.1016/j.xphs.2026.104589}
}